Literature DB >> 34755660

[Peripheral blood EMR3 gene methylation level is correlated with breast cancer in Chinese women].

X Zhou1, S Lei1, L Li2, T Xu3, W Gu3, F Ma2, R Yang1.   

Abstract

OBJECTIVE: To explore the association of methylation levels of C19orf57, MAP9, EMR3, NEK6 and PCOLCE2 genes in peripheral blood with breast cancer (BC) in Chinese women.
METHODS: We collected peripheral blood samples from 258 early-stage BC patients and 272 healthy women. Agena matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS) was utilized to quantitatively measure the methylation levels of CpG sites in the genes. The association between DNA methylation and BC was analyzed using a logistic regression model adjusted for covariants. Spearman's correlation analysis was performed to analyze the association between the gene methylation levels and age. The methylation levels of the genes in the BC patients with different clinical characteristics were investigated using non-parametric tests.
RESULTS: In stead of EMR3 gene hypermethylation as found in BC patients as found in the Caucasian population, EMR3 gene hypomethylation was found to correlate with BC in Chinese women, but this correlation was significant only in women beyond the age of 50 years (for every 10% reduction of the methylation level, EMR3_CpG_1: OR=1.40; EMR3_CpG_2: OR=2.31; EMR3_CpG_3: OR=2.76, P < 0.05). EMR3 methylation was not or was only weakly correlated with tumor stage, size, lymphatic metastasis, ER, PR, HER2, or Ki67. Our data did not show a correlation between C19orf57 methylation and BC.
CONCLUSION: Peripheral blood EMR3 gene hypomethylation is associated with BC in Chinese women, especially in those at an old age and in postmenopausal women.

Entities:  

Keywords:  DNA methylation; EMR3; MALDI-TOF; breast cancer; peripheral blood

Mesh:

Substances:

Year:  2021        PMID: 34755660      PMCID: PMC8586854          DOI: 10.12122/j.issn.1673-4254.2021.10.03

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  44 in total

Review 1.  DNA methylation and human disease.

Authors:  Keith D Robertson
Journal:  Nat Rev Genet       Date:  2005-08       Impact factor: 53.242

Review 2.  Epigenetics: a landscape takes shape.

Authors:  Aaron D Goldberg; C David Allis; Emily Bernstein
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

3.  The association between breast cancer and S100P methylation in peripheral blood by multicenter case-control studies.

Authors:  Rongxi Yang; Sarah Stöcker; Sarah Schott; Jörg Heil; Frederik Marme; Katarina Cuk; Bowang Chen; Michael Golatta; Yan Zhou; Christian Sutter; Barbara Wappenschmidt; Rita Schmutzler; Peter Bugert; Bin Qu; Claus R Bartram; Christof Sohn; Andreas Schneeweiss; Barbara Burwinkel
Journal:  Carcinogenesis       Date:  2017-03-01       Impact factor: 4.944

4.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

Review 5.  DNA methylation and its basic function.

Authors:  Lisa D Moore; Thuc Le; Guoping Fan
Journal:  Neuropsychopharmacology       Date:  2012-07-11       Impact factor: 7.853

Review 6.  Hormones and breast cancer.

Authors: 
Journal:  Hum Reprod Update       Date:  2004-06-10       Impact factor: 15.610

7.  DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood.

Authors:  Rongxi Yang; Katrin Pfütze; Manuela Zucknick; Christian Sutter; Barbara Wappenschmidt; Frederik Marme; Bin Qu; Katarina Cuk; Christoph Engel; Sarah Schott; Andreas Schneeweiss; Hermann Brenner; Rainer Claus; Christoph Plass; Peter Bugert; Markus Hoth; Christof Sohn; Rita Schmutzler; Claus R Bartram; Barbara Burwinkel
Journal:  Int J Cancer       Date:  2014-09-24       Impact factor: 7.396

Review 8.  Diet, Nutrition, and Cancer Epigenetics.

Authors:  Carmen Sapienza; Jean-Pierre Issa
Journal:  Annu Rev Nutr       Date:  2016-03-23       Impact factor: 11.848

9.  High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma.

Authors:  Kellie J Archer; Valeria R Mas; Daniel G Maluf; Robert A Fisher
Journal:  Mol Genet Genomics       Date:  2010-02-18       Impact factor: 3.291

Review 10.  Early Diagnosis of Breast Cancer.

Authors:  Lulu Wang
Journal:  Sensors (Basel)       Date:  2017-07-05       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.